Home | Welcome to Contract Pharma   
Last Updated Thursday, September 18 2014
Print RSS Feed

Search Results for 'Biogen Acquires Full Tysabri Rights'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published May 12, 2014
Rudick bring expertise in MS programs Read More »
Published February 6, 2013
Elan to receive $3.25 billion, royalties Read More »
Complying with Track and Trace
By Stephen Barlas
Published April 30, 2008
Biogen Idec blazes a path to California compliance Read More »
By WITec GmbH
By Mr. Deepak Bahri, President
By Jerome BESSE, CEO
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On